Featured
-
-
Obituary |
Anthony Epstein (1921–2024), discoverer of virus causing cancer in humans
Pathologist whose finding that viruses can trigger tumours in humans transformed medical research.
- Alan Rickinson
-
News Feature |
Why are so many young people getting cancer? What the data say
Clues to a modern mystery could be lurking in information collected generations ago.
- Heidi Ledford
-
Comment |
Why the world cannot afford the rich
Equality is essential for sustainability. The science is clear — people in more-equal societies are more trusting and more likely to protect the environment than are those in unequal, consumer-driven ones.
- Richard G. Wilkinson
- & Kate E. Pickett
-
News |
Trump versus Biden: what the rematch could mean for three key science issues
Depending on the winner of November’s election, researchers anticipate two completely different paths ahead for the environment, public health and more.
- Jeff Tollefson
- , Natasha Gilbert
- & Mariana Lenharo
-
News |
Landmark study links microplastics to serious health problems
People who had tiny plastic particles lodged in a key blood vessel were more likely to experience heart attack, stroke or death during a three-year study.
- Max Kozlov
-
Correspondence |
Personalized cancer care can’t rely on molecular testing alone
- James Larkin
- , Chloe Beland
- & Alexander R. Lyon
-
Correspondence |
Forget lung, breast or prostate cancer? Why we shouldn’t abandon tumour names yet
- Albrecht Stenzinger
- & Frederick Klauschen
-
World View |
Here’s what many digital tools for chronic pain are doing wrong
To address the chronic-pain crisis, digital health technologies must break out of their silos and become integrative and holistic.
- Benjamin Lipp
-
News |
Meningitis could be behind ‘mystery illness’ reports in Nigeria
The WHO confirms three meningitis deaths, which it says might have triggered rumours of an outbreak of an unknown disease.
- Sarah Wild
-
News |
Brazil’s record dengue surge: why a vaccine campaign is unlikely to stop it
A vaccine shortage and persistent sanitation problems threaten the success of the world’s first public vaccination campaign against dengue virus.
- Mariana Lenharo
-
Career Q&A |
‘This is my calling’: building point-of-care diagnostic tools to fight tuberculosis
Mireille Kamariza talks about her journey from community college to biotech chief executive, and the uphill battle to stop the spread of the deadly lung disease.
- Abdullahi Tsanni
-
Research Highlight |
Mpox’s surge was stopped by behaviour change — before vaccine rollout
Analysis of more than 1,000 viral genomes reveals patterns in how the disease circulated through various communities.
-
Correspondence |
Speed up relief for long COVID through grassroots clinical trials
- Marc Jamoulle
- , Elena Louazon
- & Johan Van Weyenbergh
-
News |
Influential abortion-pill studies retracted: the science behind the decision
Nature spoke to researchers about the flaws that triggered the retractions. They say these papers are just the tip of the iceberg.
- Mariana Lenharo
-
Editorial |
Science can drive development and unity in Africa — as it does in the US and Europe
A plan to establish Africa’s first continent-wide science fund should not be delayed any longer.
-
Analysis
| Open AccessMaking cities mental health friendly for adolescents and young adults
A study examining how cities can foster well-being and positive mental health in young residents synthesizes opinions from researchers, practitioners, advocates and young people, highlighting factors that policymakers and urban planners should consider.
- Pamela Y. Collins
- , Moitreyee Sinha
- & Lian Zeitz
-
Nature Podcast |
Smoking changes your immune system, even years after quitting
The lingering effect of cigarettes on T cell responses, and the Solar System's new ocean.
- Shamini Bundell
- & Nick Petrić Howe
-
News |
Introducing meat–rice: grain with added muscles beefs up protein
The laboratory-grown food uses rice as a scaffold for cultured meat.
- Jude Coleman
-
News |
Smoking scars the immune system for years after quitting
A cigarette habit and previous infection with a common virus both have important effects on the immune system.
- Heidi Ledford
-
Career Q&A |
A researcher-exchange programme made me a better doctor at home and abroad
Caleb Skipper describes how global health collaborations bring valuable transfers of knowledge to both sides of the Atlantic.
- Christopher Bendana
-
Book Review |
The ‘Bill Gates problem’: do billionaire philanthropists skew global health research?
Personal priorities are often trumping real needs and skewing where charitable funding goes.
- Andy Stirling
-
Nature Podcast |
Why we need to rethink how we talk about cancer
Naming metastatic cancers after parts of the body could be holding up research and preventing people from accessing the best treatment
- Lucy Odling-Smee
- & Noah Baker
-
Nature Careers Podcast |
‘It reflects the society we live in where a young person does not feel life is worth living’
With youth suicide rates rising, it’s vital that mental health forms part of global well-being targets, says Shekhar Saxena.
- Dom Byrne
-
News |
Why a cheap, effective treatment for diarrhoea is underused
Actors posing as dads of sick children reveal the hidden motives behind doctors’ and pharmacists’ prescription decisions.
- Smriti Mallapaty
-
Correspondence |
Clinical trials: Japan’s opt-out policy raises risks of adverse drug responses
- Mira Namba
- , Yudai Kaneda
- & Tetsuya Tanimoto
-
Nature Podcast |
Cervical cancer could be eliminated: here’s how
Two experts lay out the steps that need to be taken, and the challenges facing low- and middle-income countries.
- Nick Petrić Howe
- & Jennifer Gardiner
-
Nature Careers Podcast |
‘Blue foods’ to tackle hidden hunger and improve nutrition
Aquatic foods have been overlooked in moves to end food insecurity. That needs to change, says Christopher Golden.
- Dom Byrne
-
Comment |
Forget lung, breast or prostate cancer: why tumour naming needs to change
The conventional way of classifying metastatic cancers according to their organ of origin is denying people access to drugs that could help them.
- Fabrice André
- , Elie Rassy
- & Benjamin Besse
-
News & Views |
An early look at birth cohort genetics in China
Genetic sequencing data from more than 4,000 Chinese participants in the Born in Guangzhou Cohort Study provide insights into the population, and a snapshot of what is to come in future phases of the project.
- Nicholas John Timpson
-
News |
New genetic variants found in large Chinese mother–baby study
The study is one of the first in Asia to examine links between the genomes of mothers, babies and their health.
- Smriti Mallapaty
-
Editorial |
Research funders must join the fight for equal access to medicines
Pandemic treaty is a rare opportunity to ensure pandemic-related technologies are accessible and affordable to all.
-
Comment |
Cervical cancer kills 300,000 people a year — here’s how to speed up its elimination
Without rapid change, the World Health Organization’s goals for tackling cervical cancer by 2030 will be missed. Four experts share ways to move the needle.
- Lynette Denny
- , Ishu Kataria
- & Kathleen M. Schmeler
-
Where I Work |
Therapy dog spreads paws-itivity at cancer hospital
Marguerite Nicodeme works with Snoopy the dog to bring moments of cheerful relief to patients and their carers.
- Benjamin Plackett
-
Nature Podcast |
Audio long read: Long COVID is a double curse in low-income nations — here’s why
A dearth of research means the condition is often ignored by physicians.
- Heidi Ledford
- & Benjamin Thompson
-
Outlook |
Tracking down tuberculosis
Improvements in screening and diagnosis could help to eradicate this curable disease.
- Neil Savage
-
News |
Medical AI could be ‘dangerous’ for poorer nations, WHO warns
The rapid growth of generative AI in health care has prompted the agency to set out guidelines for ethical use.
- David Adam
-
News |
Potent new pill provides COVID relief for the masses
The drug simnotrelvir shortens symptoms for those with mild infections and is sold at a lower price in China than its main rival.
- Saima Sidik
-
Correspondence |
Centres of Excellence in AI for global health equity — a strategic vision for LMICs
- Hossein Akbarialiabad
- & Nelson K. Sewankambo
-
Outlook |
Yaws could soon be eradicated — 70 years behind schedule
Researchers are cautiously optimistic that the neglected tropical disease could be gone by 2030, but new barriers — including antibiotic resistance and primate reservoirs — might stand in the way.
- Sam Jones
-
Editorial |
A new class of antibiotics is cause for cautious celebration — but the economics must be fixed
The threat of antimicrobial resistance means that new antibiotics need to be used sparingly. Governments must support their development with a long-term funding plan.
-
News Feature |
Long COVID is a double curse in low-income nations — here’s why
Not only is the prevalence of the condition poorly understood, but it’s also often ignored by physicians and the wider public.
- Heidi Ledford
-
News & Views |
Contact-tracing app predicts risk of SARS-CoV-2 transmission
The risk of catching COVID-19 as calculated by a smartphone app scales with the probability of subsequently testing positive for the coronavirus SARS-CoV-2, showing that digital contact tracing is a useful tool for fighting future pandemics.
- Justus Benzler
-
News |
Vaccines reduce the risk of long COVID in children
A study shows that US children who received mRNA COVID-19 vaccines have some protection against developing long-lasting symptoms of the coronavirus SARS-CoV-2.
- Shannon Hall
-
Article
| Open AccessDigital measurement of SARS-CoV-2 transmission risk from 7 million contacts
Digital measurements of proximity and duration of exposure by the NHS COVID-19 app show a strong relation to actual infections among 7 million contacts notified in England and Wales, with longer durations translating to increased risk of transmission.
- Luca Ferretti
- , Chris Wymant
- & Christophe Fraser
-
News & Views |
Nausea and vomiting in pregnancy linked to hormone from fetus
Maternal sensitivity to a hormone produced by the fetus might underlie the risk of severe nausea and vomiting in human pregnancy — a finding that could open up strategies for the treatment of this debilitating condition.
- Alice E. Hughes
- & Rachel M. Freathy
-
Article |
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
An inhalable, single-dose dry powder aerosol SARS-CoV-2 vaccine shows good storage stability, results in sustained antigen delivery to antigen-presenting cells in the lungs and induces a potent antiviral immune response.
- Tong Ye
- , Zhouguang Jiao
- & Wei Wei
-
Research Highlight |
Dirty air is linked to smaller babies across huge swathes of Asia and Africa
Exposure to high levels of ozone causes mothers in low- and middle-income countries to give birth to infants with a low birth weight.
-
News Feature |
Is cannabis bad for teens? Here’s what the data say
Ten years after cannabis was first legalized for casual use in adults, scientists are struggling to provide evidence-based recommendations about the risks to young people.
- Anil Oza
-
News |
Eat less meat: will the first global climate deal on food work?
A declaration on reducing the eye-watering emissions from food production is a start, say researchers — but it sidesteps contentious issues in the role of food production in global climate change.
- Carissa Wong